49 results
8-K
EX-4.1
TCBP
TC BioPharm (Holdings) plc
8 May 24
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
8:55am
.
Section 5. Miscellaneous.
a) No Rights as Shareholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting … rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
8-K
TCBP
TC BioPharm (Holdings) plc
8 May 24
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
8:55am
of the Company’s ADSs, such holder of New Warrants does not have the rights or privileges of a holder of the Company’s ADSs, including any voting rights, until
10-K/A
2023 FY
TCBP
TC BioPharm (Holdings) plc
29 Apr 24
Annual report (amended)
5:23pm
through the exercise of any option, warrant or other right or the conversion of any other security. All shareholders have the same voting rights.
Unless
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
held through ADSs, such as voting rights or the right to receive dividends, but rather represent the right to acquire ordinary shares at a fixed price … shareholders pursuant in time to be able to exercise their right to vote.
Holders of the ADSs will not be able to exercise voting rights attaching
DEF 14A
yn8npwt6lp0n4
20 Feb 24
Definitive proxy
6:05am
PRE 14A
ndens1zdp
9 Feb 24
Preliminary proxy
3:26pm
6-K
EX-10.3
d9wjr3
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
6-K
EX-10.1
d6x3gzkjwk74p
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
6-K
EX-10.2
b9nz hy26c90
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
424B4
il1emnq9
20 Dec 23
Prospectus supplement with pricing info
6:42pm
F-1/A
EX-4.20
tduo43
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.19
7l3v9ttpla
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
yyeec7r5h24rkizyerm
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.21
egr0 3npmru
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
gm95mtu
8 Nov 23
Prospectus supplement
4:05pm
F-3/A
fw7ilx 5zop
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
F-3
EX-4.19
qppc1 72ap0xlhm21
29 Sep 23
Shelf registration (foreign)
4:05pm
F-3
c6k vuoa9glqagpbp
29 Sep 23
Shelf registration (foreign)
4:05pm
6-K
rho8ok
31 Aug 23
Current report (foreign)
8:00am